Congress trades
Haemonetics Corporation (HAE)
Free on iOS and Android.
About Haemonetics Corporation
from the company's filings and listing, as of Oct 27, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Christopher A. Simon
- Employees
- 3,009
- Listed since
- May 10, 1991
- Market value
- $5.4B
- Price to earnings (12 mo)
- 57.9
- Net income per share, as reported (12 mo)
- $2.12
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2027reported Aug 6, 2026 | $1.14 | $1.08 | $339.4M | $327.9M | EPS beatRevenue beat |
| Q4 FY2026reported May 7, 2026 | $1.29 | $1.28 | $346.4M | $336.8M | EPS in lineRevenue beat |
| Q3 FY2026reported Feb 5, 2026 | $1.31 | $1.27 | $339.0M | $331.9M | EPS beatRevenue beat |
| Q2 FY2026reported Nov 6, 2025 | $1.27 | $1.12 | $327.3M | $329.8M | EPS beatRevenue in line |
| Q1 FY2026reported Aug 7, 2025 | $1.10 | $1.01 | $321.4M | $320.0M | EPS beatRevenue in line |
| Q4 FY2025reported May 8, 2025 | $1.24 | $1.22 | $330.6M | $312.5M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2026 · proxy filed Jun 9, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Christopher A. SimonPresident and Chief Executive Officer | $1.1M | $7.6M | $3.4M | $12.0M |
| James C. D'AreccaExecutive Vice President, Chief Financial Officer | $604K | $1.8M | $1.2M | $3.6M |
| Michelle L. BasilExecutive Vice President, General Counsel | $559K | $1.7M | $1.1M | $3.4M |
| Frank W. ChanExecutive Vice President, Chief Operating Officer | $518K | $1.5M | $1.3M | $3.3M |
| Roy GalvinExecutive Vice President, Chief Commercial Officer | $550K | $1.5M | $1.0M | $3.0M |
The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $443.2M | 5,909,258 | +5.1% | 13.03% |
| Neuberger Berman Group LLC | $313.5M | 4,179,443 | +17.4% | 9.21% |
| Vanguard Portfolio Management LLC | $191.0M | 2,546,394 | -0.5% | 5.61% |
| AQR Capital Management LLCCliff Asness | $165.0M | 2,266,489 | -32.5% | 5.00% |
| Ariel Investments, LLC | $154.6M | 2,060,966 | New | 4.54% |
| Vanguard Capital Management LLC | $154.5M | 2,059,578 | -1.5% | 4.54% |
| State Street Corp | $136.4M | 1,818,186 | +2.6% | 4.01% |
| Dimensional Fund Advisors LP | $118.9M | 1,585,222 | +19.5% | 3.49% |
| Citadel Advisors LLCKen Griffin | $113.3M | 1,510,120 | +485.0% | 3.33% |
| Geode Capital Management, LLC | $96.6M | 1,287,240 | +5.6% | 2.84% |
| River Road Asset Management, LLC | $96.4M | 1,285,602 | -3.2% | 2.83% |
| Arrowstreet Capital, Limited Partnership | $86.7M | 1,155,351 | -16.5% | 2.55% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in HAE
13 disclosures of 13 on record · median 17d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | n/a | May 6, 2021 | May 25, 2021 | 19d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | n/a | May 7, 2021 | May 25, 2021 | 18d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/a | Jan 25, 2021 | Feb 9, 2021 | 15d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | n/a | Oct 16, 2020 | Nov 5, 2020 | 20d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/a | Sep 15, 2020 | Oct 13, 2020 | 28d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | n/a | Aug 14, 2020 | Aug 24, 2020 | 10d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | n/a | May 19, 2020 | Jun 16, 2020 | 28d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | n/a | Jun 1, 2020 | Jun 16, 2020 | 15d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | n/a | May 15, 2020 | Jun 10, 2020 | 26d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | n/a | May 28, 2020 | Jun 10, 2020 | 13d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | n/a | Aug 7, 2018 | Aug 24, 2018 | 17d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | n/a | Jun 7, 2018 | Jun 22, 2018 | 15d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | n/a | Jun 14, 2018 | Jun 22, 2018 | 8d |
We hold no closing prices for any row shown here, so no move is shown. Not investment advice.
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in HAE, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded HAE?
Lois Frankel, Josh Gottheimer and Gilbert Ray Cisneros, Jr. disclosed HAE transactions in the filings shown here.
How quickly are HAE trades disclosed?
Congressional disclosures took a median of 17 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 28, 2026.